China Share Price

China Share Price

AMEX: CPHI | Micro Cap | Healthcare
$0.46
+$0.46 (--%) Last updated on 20 Nov, 2026 | 02:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

China Stock Performance

Open
$0.46
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.44 - $0.46
Year Range
$0.41 - $19.18
Volume
473
Average Traded
$0.45

China Share Price Chart

Line chart of the China price trend over the selected period. The price rose overall, ranging from 0.49 to 0.50, ending at 0.49.
$0.44$0.46
L
Show Current Price
H

China Stock Fundamentals & Key Indicators

Market Cap
$1.95M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.10
Revenue (TTM)
$4.14B
Return On Equity (TTM)
-12.37%
Profit Margin
-77.05%
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-124.62%

China Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.76$1.23$0.98$0.95
Net Profit-$0.65-$1.22-$1.14-$1.46
Net Profit Margin-85.53%-99.19%-116.33%-153.68%
Income ChangeN/A-87.69%6.56%-28.07%

China Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.10$7.01$4.53$4.14
Net Profit-$3.97-$3.08-$4.74-$3.19
Net Profit Margin-49.01%-43.94%-104.64%-77.05%
Income ChangeN/A22.42%-53.90%32.70%

China Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets28.6511.6210.4711.82
Current Assets2.353.276.05.96
Total Assets31.014.8916.4717.78
Non Current Liabilities0.862.122.190.75
Current Liabilities7.45.026.8212.74
Total Liabilities8.267.149.0113.49
Shareholders' Equity22.747.757.454.29

China Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating0.15-0.41-0.7-0.41
Investing-0.14-0.29-0.01-0.4
Financing-0.29-0.030.07-1.77

Corporate Actions

Split
Ex-date: 15 Apr 2025

Split
Ex-date: 06 Mar 2024

Split
Ex-date: 06 Mar 2023

About China

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.62
$0.46
-26.61%
Oct 2026
$0.65
$0.62
-6.34%
Sep 2026
$0.88
$0.66
-26.44%
Aug 2026
$1.20
$0.90
-18.55%
Jul 2026
$0.75
$1.10
+68.96%
Jun 2026
$0.82
$0.65
-19.26%
May 2026
$0.41
$0.81
+30.65%
Apr 2026
$0.62
$0.62
+2.48%
Mar 2026
$0.57
$0.60
-13.45%
Feb 2026
$1.05
$0.70
-37.59%
Jan 2026
$1.33
$1.12
-15.15%
Dec 2025
$1.80
$1.32
-17.50%

China Share Price FAQs